Codex: Synthetic DNA/mRNA Instrument Developer Holds Impressive Upside In 2021

alengo/E+ via Getty Images
Graphic Source: Codex DNA, Inc.
Introduction: What is Codex DNA?
Codex DNA, Inc. (NASDAQ: DNAY) is a focused synthetic biology company developing lab instruments, reagents, and associated products while providing various other…

Click here to view the original article.